CsA was demonstrated to prevent LPS-induced caspase-1 activation and IL-1β secretion in BMDM [99,109,110] and was able to prevent astrocytic reactivity in AD models [206], albeit through calcineurin inhibition [111]. Here, IL1B is linked to Alzheimer disease.